1-2 of 2
Jia Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors

Zeng Wang, Meijun Zheng, Mengyao Li, Huaqing Lu, Nanxi Liu, Yongdong Chen, Nian Yang, Wanqin Zeng, Yijun Dong, Jia Li, Zhixiong Zhu, Chen Yang, Zongliang Zhang, Qizhong Lu, Hexian Li, Liangxue Zhou, Hui Yang, Aiping Tong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF14.
https://doi.org/10.1158/1535-7163.MCT-24-0319
Published: 16 December 2024
View article titled, Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors
Open the PDF for Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract C21: Hypoxia‐induced down‐regulation of BRCA1 nuclear protein in human breast cancer tissues

Jia Li, Catherine AW. Sullivan, Veronique Numeister, David L. Rimm, Peter M. Glazer, Lyndsay Harris
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C21.
https://doi.org/10.1158/1535-7163.TARG-09-C21
Published: 10 December 2009
View article titled, Abstract C21: Hypoxia‐induced down‐regulation of BRCA1 nuclear protein in human breast cancer tissues